Developing a Targeted Learning-Based Statistical Analysis Plan

References

• Bang, H., and Robins, J. M. (2005), “Doubly Robust Estimation in Missing Data and Causal Inference Models,” Biometrics, 61, 962–973. DOI: 10.1111/j.1541-0420.2005.00377.x.
   PubMed Web of Science ®Google Scholar
• Benkeser, D., Carone, M., and Gilbert, P. B. (2017), “Targeted Estimates of Marginal Cumulative Incidence in Survival Settings with and without Competing Risks, Including Estimators that Respect Bounds,” Statistics in Medicine, 37, 280–293.
   PubMedGoogle Scholar
• Cai, W., and van der Laan, M. (2020), “Nonparametric Bootstrap Inference for the Targeted Highly Adaptive Least Absolute Shrinkage and Selection Operator (lasso) Estimator,” The International Journal of Biostatistics, 16, 20170070. DOI: 10.1515/ijb-2017-0070.
   Google Scholar
• Colson, K. E., Rudolph, K. E., Zimmerman, S. C., Goin, D. E., Stuart, E. A., van der Laan, M., and Ahern, J. (2016), “Optimizing Matching and Analysis Combinations for Estimating Causal Effects,” Scientific Reports, 6, 1–11. DOI: 10.1038/srep23222.
   PubMed Web of Science ®Google Scholar
• Coyle, J., and van der Laan, M. J. (2018), “Targeted Bootstrap,” in Targeted Learning in Data Science, pp. 523–539, Cham: Springer.
   Google Scholar
• Diaz, I., and van der Laan, M. J. (2013), “Sensitivity Analysis for Causal Inference under Unmeasured Confounding and Measurement Error Problems,” International Journal of Biostatistics, 9, 149–160.
   Web of Science ®Google Scholar
• Ferreira, G. S., Schnitzer, M. E., Forget, A., and Blais, L. (2020), “Impact of Discretization of the Timeline for Longitudinal Causal Inference Methods,” Statistics in Medicine, 39, 4069–4085. DOI: 10.1002/sim.8710.
   PubMed Web of Science ®Google Scholar
• Gamble, C., Krishan, A., Stocken, D., Lewis, S., Juszczak, E., Doré, C., Williamson, P. R., Altman, D. G., Montgomery, A., Lim, P., Berlin, J., Senn, S., Day, S., Barbachano, Y., and Loder, E. (2017), “Guidelines for the Content of Statistical Analysis Plans in Clinical Trials,” JAMA, 318, 2337–2343. DOI: 10.1001/jama.2017.18556.
   PubMed Web of Science ®Google Scholar
• Goldstein, B. A., Bhavsar, N. A., Phelan, M., and Pencina, M. J. (2016), “Controlling for Informed Presence Bias Due to the Number of Health Encounters in an Electronic Health Record,” American Journal of Epidemiology, 184, 847–855. DOI: 10.1093/aje/kww112.
   PubMed Web of Science ®Google Scholar
• Gruber, S. (2018), “Targeted Learning with Application to Health Care Research,” in Biomedical Signal Processing in Big Data, eds. E. Sejdic and T. H. Falk, CRC Press, 235–255.
   Google Scholar
• Gruber, S., and van der Laan, M. (2012), “tmle: An R Package for Targeted Maximum Likelihood Estimation,” Journal of Statistical Software, 51, 1–35. DOI: 10.18637/jss.v051.i13.
   PubMed Web of Science ®Google Scholar
• Gruber, S., and van der Laan, M. (2013), “An Application of Targeted Maximum Likelihood Estimation to the Meta-Analysis of Safety Data,” Biometrics, 69, 254–262.
   PubMed Web of Science ®Google Scholar
• Gruber, S., Phillips, R. V., Lee, H., Ho, M., Concato, J., and van der Laan, M. J. (2022), “Targeted Learning: Towards a Future Informed by Real-World Evidence,” https://arxiv.org/abs/2205.08643.
   Google Scholar
• Hernan, M. A., Brumback, B., and Robins, J. M. (2000), “Marginal Structural Models to Estimate the Causal Effect of Zidovudine on the Survival of HIV-Positive Men,” Epidemiology, 11, 561–570.
   PubMed Web of Science ®Google Scholar
• Ho, M., van der Laan, M., Lee, H., Chen, J., Lee, K., Fang, Y., He, W., Irony, T., Jiang, Q., Lin, X., Meng, Z., Mishra-Kalyani, P., Rockhold, F., Song, Y., Wang, H., and White, R. (2021), “The Current Landscape in Biostatistics of Real-World Data and Evidence: Causal Inference Frameworks for Study Design and Analysis,” Statistics in Biopharmaceutical Research, 1–14. DOI: 10.1080/19466315.2021.1883475.
   Web of Science ®Google Scholar
• ICH (2019), “Harmonised Guideline E9(R1)Addendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guideline on Statistical Principles for Clinical Trials E9(R1),” International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.
   Google Scholar
• Imbens, G. W., and Angrist, J. D. (1994), “Identification and Estimation of Local Average Treatment Effects,” Econometrica, 62, 467–475. DOI: 10.2307/2951620.
   Web of Science ®Google Scholar
• Ju, C. (2021), “ctmle: Collaborative Targeted Maximum Likelihood Estimation,” available at http://CRAN.R-project.org/package=ctmle. Accessed October 19, 2021.
   Google Scholar
• Lendle, S., Fireman, B., and van der Laan, M. (2013), “Targeted Maximum Likelihood Estimation in Safety Analysis,” Journal of Clinical Epidemiology Analytic Issues in Comparative Effectiveness Research, 66, S91–S98. DOI: 10.1016/j.jclinepi.2013.02.017.
   Google Scholar
• Naimi, A. I., and Balzer, L. B. (2018), “Stacked Generalization: An Introduction to Super Learning,” European Journal of Epidemiology, 33, 459–464. DOI: 10.1007/s10654-018-0390-z.
   PubMed Web of Science ®Google Scholar
• Neugebauer, R., Fireman, B., Roy, R. A., Raebel, M. A., Nichols, G. A., and O’Connor, P. J. (2013), “Super Learning to Hedge Against Incorrect Inference from Arbitrary Parametric Assumptions in Marginal Structural Modeling,” Journal of Clinical Epidemiology, 66, S99–S109. DOI: 10.1016/j.jclinepi.2013.01.016.
   PubMed Web of Science ®Google Scholar
• Pearl, J. (2000), Causality: Models, Reasoning, and Inference (2nd ed.), Cambridge: Cambridge University Press.
   Google Scholar
• Petersen, M. L., Schwab, J., Gruber, S., Blaser, N., Schomaker, M., and van der Laan, M. (2014), “Targeted Maximum Likelihood Estimation for Dynamic and Static Longitudinal Marginal Structural Working Models,” Journal of Causal Inference, 2, 147–185. DOI: 10.1515/jci-2013-0007.
   PubMedGoogle Scholar
• Petersen, M. L., and van der Laan, M. J. (2014), “Causal Models and Learning from Data: Integrating Causal Modeling and Statistical Estimation,” Epidemiology, 25, 418–426. DOI: 10.1097/EDE.0000000000000078.
   PubMed Web of Science ®Google Scholar
• Phillips, R. V., van der Laan, M. J., Lee, H., and Gruber, S. (2022), “Practical Considerations for Specifying a Super Learner,” https://arxiv.org/abs/2204.06139.
   Google Scholar
• Polley, E. C. (2021), “Super Learner in Prediction, v2.0-24,” available at http://CRAN.R-project.org/package=SuperLearner. Accessed October 19, 2021.
   Google Scholar
• Polley, E. C., and van der Laan, M. J. (2010), “Super Learner in Prediction,” Technical Report 200, U.C. Berkeley Division of Biostatistics Working Paper Series.
   Google Scholar
• Public Policy Committee, International Society of Pharmacoepidemiology. (2016), “Guidelines for Good Pharmacoepidemiology Practice (GPP),” Pharmacoepidemiology and Drug Safety, 25, 2–10.
   PubMed Web of Science ®Google Scholar
• Putnam Data Sciences (2021), “Targeted Learning Webinar Series,” available at https://putnamds.com/#TargetedLearning. Accessed October 19, 2021.
   Google Scholar
• Ratitch, B., O’Kelly, M., and Tosiello, R. (2013), “Missing Data in Clinical Trials: From Clinical Assumptions to Statistical Analysis using Pattern Mixture Models,” Pharmaceutical statistics, 12, 337–347. DOI: 10.1002/pst.1549.
   PubMed Web of Science ®Google Scholar
• Rudolph, J. E., Lesko, C. R., and Naimi, A. I. (2020), “Causal Inference in the Face of Competing Events,” Current Epidemiology Reports, 7, 125–131. DOI: 10.1007/s40471-020-00240-7.
   PubMedGoogle Scholar
• Rytgaard, H. C. W., and van der Laan, M. J. (2021), “One-Step tmle for Targeting Cause-Specific Absolute Risks and Survival Curves,” arXiv preprint arXiv:2107.01537.
   Google Scholar
• Schnitzer, M. (2020), “The Causal Inference of Longitudinal Exposures with Marginal Structural Models: An Overview and Application of Longitudinal tmle,” [Webinar], available at https://youtu.be/_C3BRowGGfI.
   Google Scholar
• Schnitzer, M., Moodie, E., and Platt, R. (2013), “Targeted Maximum Likelihood Estimation for Marginal Time-Dependent Treatment Effects under Density Misspecification,” Biostatistics, 14, 1–14. DOI: 10.1093/biostatistics/kxs024.
   PubMed Web of Science ®Google Scholar
• Schomaker, M., Luque-Fernandez, M. A., Leroy, V., and Davies, M. A. (2019), “Using Longitudinal Targeted Maximum Likelihood Estimation in Complex Settings with Dynamic Interventions,” Statistics in Medicine, 38, 4888–4911. DOI: 10.1002/sim.8340.
   PubMed Web of Science ®Google Scholar
• Schwab, J. (2021), “ltmle: Longitudinal Targeted Maximum Likelihood Estimation,” available at http://CRAN.R-project.org/package=ltmle. Accessed October 19, 2021.
   Google Scholar
• Sekhon, J. S. (2008), “The Neyman-Rubin Model of Causal Inference and Estimation via Matching Methods,” The Oxford Handbook of Political Methodology, eds. J. Box-Steffensmeier, H. Brady, and D. Collier, 271–299, Oxford: Oxford University Press.
   Google Scholar
• Sofrygin, O., Zhu, Z., Schmittdiel, J. A., Adams, A. S., Grant, R. W., van der Laan, M. J., and Neugebauer, R. (2019), “Targeted Learning with Daily EHR Data,” Statistics in Medicine, 38, 3073–3090. DOI: 10.1002/sim.8164.
   PubMed Web of Science ®Google Scholar
• Thabane, L., Mbuagbaw, L., and Zhang, S. (2013), “A Tutorial on Sensitivity Analyses in Clinical Trials: The What, Why, When and How,” BMC Medical Research Methodology, 13. DOI: 10.1186/1471-2288-13-92.
   Web of Science ®Google Scholar
• Tran, L., Petersen, M., Schwab, J., and van der Laan, M. J. (2018), “Robust Variance Estimation and Inference for Causal Effect Estimation,” arXiv preprint arXiv:1810.03030.
   Google Scholar
• United States Food and Drug Administration (2008), “Guidance for Sponsors, Clinical Investigators, and IRBs: Data Retention when Subjects Withdraw from FDA-Regulated Clinical Trials, available atwww.fda.gov/media/75138/download. Accessed August 30, 2021.
   Google Scholar
• United States Food and Drug Administration (2013), “Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Guidance for Industry and FDA Staff. Best Practices for Conducting and Reporting Pharmacoepidemiologic Safety Studies using Electronic Healthcare Data,” available at https://www.fda.gov/files/drugs/published/Best-Practices-for-Conducting-and-Reporting-Pharmacoepidemiologic-Safety-Studies-Using-Electronic-Healthcare-Data-Sets.pdf. Accessed August 30, 2021.
   Google Scholar
• United States Food and Drug Administration (2021), “Real-World Data: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision-Making for Drug and Biological Products,” available at https://www.fda.gov/regulatory-information/search-fda-guidance-documents/real-world-data-assessing-electronic-health-records-and-medical-claims-data-support-regulatory. Accessed May 16, 2022.
   Google Scholar
• van der Laan, M., and Gruber, S. (2012), “Targeted Minimum Loss based Estimation of Causal Effects of Multiple Timepoint Interventions,” The International Journal of Biostatistics, 8, 1–39.
   Google Scholar
• van der Laan, M. J., and Rose, S. (2011), Targeted Learning: Prediction and Causal Inference for Observational and Experimental Data (1st ed.), New York: Springer.
   Google Scholar
• van der Laan, M. J., and Rose, S. (2018), Targeted Learning in Data Science: Causal Inference for Complex Longitudinal Studies (1st ed.), New York: Springer.
   Google Scholar
• van der Laan, M. J., and Rubin, D. (2006), “Targeted Maximum Likelihood Learning,” International Journal of Biostatistics, 2, 1–38.
   Google Scholar
• van der Laan, M. J., Polley, E., and Hubbard, A. (2007), “Super Learner,” Statistical Applications in Genetics and Molecular Biology, 6, 1–21. DOI: 10.2202/1544-6115.1309.
   Web of Science ®Google Scholar